Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$215,236
-$236,096 QoQ
Shares Held
715
-37.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#584
of 780 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLOW TRADERS U.S. LLC holds $1,634,905 across 8 Biotechnology names. ALNY ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
795 | $737,577 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,371 | $681,016 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
715 | $215,236 | |
| 4 | SGMOQ |
Sangamo Therapeutics, Inc
|
21,532 | $1,076 | |
| 5 | 24,173 | $0 | |||
| 6 | ASBP |
Aspire Biopharma Holdings, Inc.
|
15,450 | $0 | |
| 7 | TVGN |
Tevogen Inc.
|
17,649 | $0 | |
| 8 | LIMN |
Liminatus Pharma, Inc.
|
13,110 | $0 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,236 | 715 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $451,332 | 1,135 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $241,306 | 740 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $327,551 | 1,392 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||